Company Update

ANG Lifesciences India Limited has submitted its Annual Secretarial Compliance Report, confirming adherence to applicable statutory provisions and corporate governance practices for the financial year ended March 31, 2025. The company maintained proper board processes, timely updated required policies, preserved documents as per regulations, and ensured accurate disclosures on its website.

A delay was noted in submitting the Reconciliation of Share Capital Audit for the June and September 2024 quarters, which has since been rectified.

No director disqualifications or regulatory actions by SEBI or stock exchanges were reported.

The company's auditor resigned within 45 days after quarter-end but had issued all requisite audit reports before resignation.